v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities        
Net loss   $ (214,889,000) $ (305,909,000) $ (175,587,000)
Adjustments to reconcile Net loss to Net cash provided by (used in) operating activities:        
Depreciation, amortization and accretion   88,201,000 96,254,000 133,803,000
(Gain) loss on deconsolidation, net   0 (5,622,000) 0
Impairment of goodwill   0 221,314,000 0
Impairment of long-lived assets, net   40,056,000 74,782,000 59,294,000
(Gain) loss on asset disposition   95,339,000 12,932,000 0
(Gain) loss on asset disposition     12,656,000  
(Gain) loss on extinguishment of liabilities   (15,417,000) 0 0
Share-based compensation expense   10,805,000 378,000 11,248,000
Change in fair value of contingent consideration   (300,000) (39,348,000) (603,000)
Amortization of financing costs and debt discounts   7,967,000 6,261,000 6,711,000
Amortization of interest rate swap contracts   (5,905,000) (1,055,000) 6,750,000
Change in fair value of interest rate swaps, net   26,223,000 (44,748,000) (17,763,000)
(Gain) loss on interest rate swaps, net   (5,485,000) (1,356,000) (2,428,000)
Change in fair value of investments, net   5,380,000 14,701,000 (932,000)
Deferred income taxes   (8,124,000) (19,378,000) (21,548,000)
Interest expense on failed sale-leaseback financing and deferred ITC gain   6,282,000 7,549,000 0
Income from sale-leaseback transfer of tax benefits   (32,951,000) (22,764,000) 0
Other   7,335,000 3,565,000 5,743,000
Changes in operating assets and liabilities:        
Accounts receivable   (11,095,000) (4,864,000) (2,959,000)
Current and noncurrent derivative assets   17,934,000 52,602,000 56,696,000
Other current and noncurrent assets   (7,346,000) 9,416,000 (10,661,000)
Accounts payable and accrued expenses   (6,340,000) 14,164,000 14,891,000
Operating lease liabilities   (1,029,000) (1,543,000) (1,290,000)
Other current and noncurrent liabilities   46,999,000 420,000 1,036,000
Net cash provided by (used in) operating activities   43,640,000 67,475,000 62,401,000
Cash Flows from Investing Activities        
Purchases of property, plant and equipment   (520,711,000) (287,822,000) (360,650,000)
Net deposits (paid) returned for property, plant and equipment   (1,221,000) 8,155,000 8,138,000
Proceeds from sale of assets   237,362,000 36,563,000 0
Insurance proceeds for damaged equipment   2,278,000 0 0
Return of capital on investments   3,000,000 6,775,000 3,906,000
Loans made to other parties   0 (19,742,000) 0
Receipts from notes receivable   71,000 46,204,000 30,725,000
Other investing activities   (218,000) (734,000) (5,298,000)
Net cash used in investing activities   (279,439,000) (210,601,000) (323,179,000)
Cash Flows from Financing Activities        
Shareholder distributions $ (87,597,000) 0 (37,196,000)  
Return of collateral paid for swap contract 1,735,000 0 0  
Repurchases of common shares (82,719,000) (2,667,000) (6,428,000)  
Shares withheld related to net share settlement of equity awards 0 (2,827,000) (1,880,000)  
Deferred shareholder servicing fees (3,486,000) (2,229,000) (3,150,000)  
Contributions from noncontrolling interests, net 144,895,000 55,765,000 110,216,000  
Distributions to noncontrolling interests (17,498,000) (64,123,000) (17,850,000)  
Buyout of noncontrolling interests (865,000) (3,573,000) (745,000)  
Proceeds from borrowings 425,532,000 672,477,000 404,580,000  
Payments on borrowings (351,764,000) (484,721,000) (320,174,000)  
Proceeds from failed sale-leaseback 240,969,000 0 111,453,000 241,000,000.0
Payments on failed sale-leaseback 0 (1,399,000) (87,089,000)  
Payments for loan origination costs (11,447,000) (5,149,000) (34,698,000)  
Net cash provided by financing activities 257,755,000 161,554,000 117,039,000  
Net decrease in Cash, cash equivalents and Restricted cash   (74,245,000) (26,087,000) (3,023,000)
Cash, cash equivalents and Restricted cash at beginning of period $ 190,698,000 161,588,000 187,675,000 190,698,000
Cash, cash equivalents and Restricted cash at end of period   $ 87,343,000 $ 161,588,000 $ 187,675,000